Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 7323129, 8 pages
https://doi.org/10.1155/2017/7323129
Research Article

A New Chinese Medicine Intestine Formula Greatly Improves the Effect of Aminosalicylate on Ulcerative Colitis

1Department of Gastroenterology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China
2Department of Traditional Chinese Medicine, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China
3Administrative Logistics, The 2nd Dental Center, Peking University School of Stomatology, Beijing 100101, China

Correspondence should be addressed to Xuehua Piao

Received 15 February 2017; Revised 13 August 2017; Accepted 29 August 2017; Published 20 November 2017

Academic Editor: Steve Harakeh

Copyright © 2017 Baohai Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Furrie, S. Macfarlane, J. H. Cummings, and G. T. Macfarlane, “Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response,” Gut, vol. 53, no. 1, pp. 91–98, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Liu, X. Piao, L. Guo, S. Liu, F. Chai, and L. Gao, “Ursolic acid protects against ulcerative colitis via anti-inflammatory and antioxidant effects in mice,” Molecular Medicine Reports, vol. 13, no. 6, pp. 4779–4785, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Cosnes, C. Gowerrousseau, P. Seksik, and A. Cortot, “Epidemiology and natural history of inflammatory bowel diseases,” Gastroenterology, vol. 140, no. 6, pp. 1785–1794, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Q. Ouyang, R. Tandon, K. L. Goh et al., “The emergence of inflammatory bowel disease in the Asian Pacific region,” Current Opinion in Gastroenterology, vol. 21, no. 4, pp. 4408–4413, 2005. View at Google Scholar
  5. K. Asakura, Y. Nishiwaki, N. Inoue, T. Hibi, M. Watanabe, and T. Takebayashi, “Prevalence of ulcerative colitis and Crohn's disease in Japan,” Journal of Gastroenterology, vol. 44, no. 7, pp. 659–665, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Prideaux, M. A. Kamm, P. P. De Cruz, F. K. L. Chan, and S. C. Ng, “Inflammatory bowel disease in Asia: a systematic review,” Journal of Gastroenterology and Hepatology, vol. 27, no. 8, pp. 1266–1280, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. S.-K. Yang, S. Yun, J.-H. Kim et al., “Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: a KASID study,” Inflammatory Bowel Diseases, vol. 14, no. 4, pp. 542–549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. K. M. Sakthivel and C. Guruvayoorappan, “Protective effect of acacia ferruginea against ulcerative colitis via modulating inflammatory mediators, cytokine profile and NF-κB signal transduction pathways,” Journal of Environmental Pathology, Toxicology and Oncology, vol. 33, no. 2, pp. 83–98, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. Katz, “Advances in the medical therapy of inflammatory bowel disease,” Current Opinion in Gastroenterology, vol. 18, no. 4, pp. 435–440, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. C. J. Ooi and B. E. Sands, “Treatment of ulcerative colitis,” Current Opinion in Gastroenterology, vol. 15, no. 4, pp. 298–301, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Chen, Y. Yang, C. Hu et al., “Protective effects of Huangqin Decoction against ulcerative colitis and associated cancer in mice,” Oncotarget, vol. 7, no. 38, pp. 61643–61655, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Chen, X. Zhou, L. Zhang et al., “Anti-inflammatory effects of Huangqin tang extract in mice on ulcerative colitis,” Journal of Ethnopharmacology, vol. 162, pp. 207–214, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Kawashima, A. Nomura, T. Makino, K.-I. Saito, and Y. Kano, “Pharmacological properties of traditional medicine (XXIX): effect of hange-shashin-to and the combinations of its herbal constituents on rat experimental colitis,” Biological & Pharmaceutical Bulletin, vol. 27, no. 10, pp. 1599–1603, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Ke, P. K. Yadav, and L. Z. Ju, “Herbal medicine in the treatment of ulcerative colitis,” Saudi Journal of Gastroenterology, vol. 18, no. 1, pp. 3–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Zhao, H. Wu, A. Zhao et al., “The in vivo and in vitro study of polysaccharides from a two-herb formula on ulcerative colitis and potential mechanism of action,” Journal of Ethnopharmacology, vol. 153, no. 1, pp. 151–159, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Rutgeerts, W. J. Sandborn, B. G. Feagan et al., “Infliximab for induction and maintenance therapy for ulcerative colitis,” The New England Journal of Medicine, vol. 353, no. 23, pp. 2462–2476, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. G. R. D'Haens, W. J. Sandborn, G. Zou et al., “Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis,” Alimentary Pharmacology & Therapeutics, vol. 46, no. 3, pp. 292–302, 2017. View at Publisher · View at Google Scholar
  18. W. H. Ren, M. Lai, Y. Chen, E. J. Irvine, and Y. X. Zhou, “Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn's disease,” Inflammatory Bowel Diseases, vol. 13, no. 7, pp. 903–910, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Oishi, K. Tokuhara, H. Miki et al., “Temporal and spatial dependence of inflammatory biomarkers and suppression by fluvastatin in dextran sodium sulfate-induced rat colitis model,” Digestive Diseases and Sciences, vol. 59, no. 9, pp. 2126–2135, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. U. Billmeier, W. Dieterich, M. F. Neurath, and R. Atreya, “Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases,” World Journal of Gastroenterology, vol. 22, no. 42, pp. 9300–9313, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. A. K. Bhan, E. Mizoguchi, R. N. Smith, and A. Mizoguchi, “Spontaneous chronic colitis in TCRα-mutant mice; an experimental model of human ulcerative colitis,” International Reviews of Immunology, vol. 19, no. 1, pp. 123–138, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Soufli, R. Toumi, H. Rafa, and C. Touil-Boukoffa, “Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases,” World Journal of Gastrointestinal Pharmacology and Therapeutics, vol. 7, no. 3, pp. 353–360, 2016. View at Publisher · View at Google Scholar
  23. X.-L. Jiang and H.-F. Cui, “An analysis of 10218 ulcerative colitis cases in China,” World Journal of Gastroenterology, vol. 8, no. 1, pp. 158–161, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. D.-Y. Liu, C.-S. Pan, Y.-Y. Liu et al., “Huang Qi Jian Zhong pellet attenuates TNBS-induced colitis in rats via mechanisms involving improvement of energy metabolism,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 574629, 14 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. W. C. You, W. C. Lin, J. T. Huang, and C. C. Hsieh, “Indigowood root extract protects hematopoietic cells, reduces tissue damage and modulates inflammatory cytokines after total-body irradiation: does Indirubin play a role in radioprotection?” Phytomedicine, vol. 16, no. 12, pp. 1105–1111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Chien, Y. Lin, F. Peng et al., “Gastroprotective potential against indomethacin and safety assessment of the homology of medicine and food formula cuttlebone complex,” Food Funct., vol. 6, no. 8, pp. 2803–2812, 2015. View at Publisher · View at Google Scholar
  27. X. He, X. Wang, J. Fang et al., “Bletilla striata: medicinal uses, phytochemistry and pharmacological activities,” Journal of Ethnopharmacology, vol. 195, pp. 20–38, 2017. View at Publisher · View at Google Scholar
  28. L. Ding, X. Shan, X. Zhao et al., “Spongy bilayer dressing composed of chitosan–Ag nanoparticles and chitosan–Bletilla striata polysaccharide for wound healing applications,” Carbohydrate Polymers, vol. 157, pp. 1538–1547, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Yin, S. L. Heo, and M. H. Wang, “Antioxidant and antidiabetic activities of extracts from Cirsium japonicum roots,” Nutrition Research and Practice, vol. 2, no. 4, pp. 247–251, 2008. View at Publisher · View at Google Scholar
  30. J.-Y. Han, S.-Y. Ahn, C.-S. Kim et al., “Protection of apigenin against kainate-induced excitotoxicity by anti-oxidative effects,” Biological & Pharmaceutical Bulletin, vol. 35, no. 9, pp. 1440–1446, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. W.-C. Lee, H. A. Jung, J. S. Choi, Y. S. Kim, and S.-M. Lee, “Protective effects of luteolin against apoptotic liver damage induced by D-galactosamine/lipopolysaccharide in mice,” Journal of Natural Products, vol. 74, no. 9, pp. 1916–1921, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. W. Gao, Y. Guo, C. Wang et al., “Indirubin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice through the inhibition of inflammation and the induction of Foxp3-expressing regulatory T cells,” Acta Histochemica, vol. 118, no. 6, pp. 606–614, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. X. L. Huang, X. Zhang, X. Y. Fei et al., “Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiation,” World Journal of Gastroenterology, vol. 22, no. 22, pp. 5201–5210, 2016. View at Google Scholar
  34. Y. Tolga, C. A. Mansur, and G. H. Savas, “Plasma viscosity: a potential predictor of both medical treatment response and clinical stage of ulcerative colitis,” Annali Italiani Di Chirurgia, vol. 87, pp. 531–543, 2016. View at Google Scholar
  35. H. Shimizu, K. Arai, J. Tang, K. Hosoi, and R. Funayama, “5-Aminosalicylate intolerance causing exacerbation in pediatric ulcerative colitis,” Pediatrics International, vol. 59, no. 5, pp. 583–587, 2017. View at Publisher · View at Google Scholar
  36. R. Keil, M. Wasserbauer, Z. Zádorová et al., “Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn’s disease and ulcerative colitis,” Scandinavian Journal of Gastroenterology, vol. 51, no. 9, pp. 1062–1068, 2016. View at Publisher · View at Google Scholar · View at Scopus